Download PDF Flyer
Impact Factor Current: 3.116
5 - Year: 3.309

Current Pharmaceutical Design

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Volume 28 , Issue 46 , 2022

This journal supports open access

Back Journal Home
Impact Factor
Web of Science Impact Factor

Current: 3.116
5 - Year: 3.309

Ranking & Category

  • 114th of 261 in Pharmacology & Pharmacy

Topic(s) Covered

1 Topic(s)

View
Covered Disease(s)

0 Disease(s)

Aims & Scope

Current Pharmaceutical Design publishes timely in-depth reviews/ mini reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Abstracted/Indexed in


Biochemistry & Biophysics Citation Index®, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Current Contents® - Life Sciences, Custom Information Services®, Dimensions, EBSCO, EMBASE/Excerpta Medica, ERA 2018, Genamics JournalSeek, Google Scholar, InCites, Index Copernicus, Index to Scientific Reviews®, J-Gate, Journal Citation Reports/Science Edition, JournalTOCs, MediaFinder®-Standard Periodical Directory, Medical Documentation Service®, MEDLINE/PubMed/Index Medicus, Open Abstracts (I4OA), Norwegian Register, PubsHub, QOAM, Research Alert®, Science Citation Index Expanded™ (SciSearch®), Science Citation Index®, Scilit, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory.

Journal History

Current Pharmaceutical Design was introduced in 1995. Prof. Alessandro Antonelli serves as the Editor-in-Chief of the journal.

Abstracted/Indexed in
COPE COMPLIANT
Endorsement(s)
""Current Pharmaceutical Design is a necessity for scientists working in the multidisciplinary fields encompassing the areas of drug design and discovery."

Annette M. Doherty
Pfizer Global R&D France
Authors' Comments

Thank you for the high quality of your services and it was such a pleasure and learning experience working with you.

Menglin Li
(School of Basic Medical Science, Beijing University of Chinese Medicine, Beijing 100029, China)

© 2022 Bentham Science Publishers | Privacy Policy